Update on Regulatory Review of Aducanumab in the European Union
Go back to Update on Regulatory Review of Aducanumab in the European Union| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.04 -0.61 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.65 | 52 Week High | $333.65 | |||
| Open | $218.11 | 52 Week Low | $223.02 | |||
| Day High | $219.30 | P/E | 27.66 | |||
| Day Low | $213.60 | EPS | $7.81 | |||
| Volume | 785,373 | |||||
